Top

Published in:

01-03-2013

Distribution of Smoking Relapse Prevention Materials in the Hispanic Community: Lessons Learned

Authors: Anamaría Bejarano, Erika B. Litvin, Gwendolyn P. Quinn, Thomas H. Brandon, Vani Nath Simmons

Published in: Journal of Cancer Education | Issue 1/2013

Abstract

There is a dearth of Spanish language, culturally relevant tobacco-related information available to Hispanics in the USA. The primary aim of this study was to examine the distribution process of Libres para Siempre (Forever Free), a Spanish language smoking relapse prevention booklet series, by health care and social service agencies serving Hispanic individuals in Florida. Representatives (N = 16) from ten agencies that requested copies of the booklets completed a semi-structured interview to assess strategies used to distribute the booklets to their Hispanic clients. As a secondary aim, we obtained feedback regarding the booklets’ quality and utility from the representatives. Results revealed that many agencies used both active and passive approaches to distribute the booklets. Issues related to distribution included language barriers between staff and clients and confusion regarding identification of the target population. Results indicated that the booklets were received favorably, and providers would recommend them to future clients.

CDC (2008) Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000–2004. Morb Mortal Weekly Rep 57:1226–1228

CDC (2011) Quitting smoking among adults—United States, 2001–2010. Morb Mortal Weekly Rep 60:1513–1519

Hughes JR, Keely J, Naud S (2004) Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99:29–38PubMedCrossRef

Trinidad DR, Perez-Stable EJ, White MM, Emery SL, Messer K (2011) A nationwide analysis of US racial/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors. Am J Public Health 101:699–706PubMedCrossRef

Webb MS, Rodriguez-Esquivel D, Baker EA (2010) Smoking cessation interventions among Hispanics in the United States: a systematic review and mini meta-analysis. Am J Health Promot 25:109–118PubMedCrossRef

U.S. Census Bureau (2010) Facts for features: Hispanic heritage month, 2010—Sept. 15–Oct. 15 2010. At http://www.census.gov/newsroom/releases/archives/facts_for_features_special_edition/cb10-ff17.html. Accessed 5 July 2011

CDC (2010) Vital signs: current cigarette smoking among adults aged ≥18 years—United States, 2009. Morb Mortal Weekly Rep 59:1135–1140

Baezconde-Garbanati L, Beebe LA, Perez-Stable EJ (2007) Building capacity to address tobacco-related disparities among American Indian and Hispanic/Latino communities: conceptual and systemic considerations. Addiction 102(Suppl 2):112–122PubMedCrossRef

Perez-Stable EJ, Ramirez A, Villareal R, Talavera GA, Trapido E, Suarez L, Marti J, McAlister A (2001) Cigarette smoking behavior among US Latino men and women from different countries of origin. Am J Public Health 91:1424–1430PubMedCrossRef

10.

Heron M (2012) Deaths: leading causes for 2008. Natl Vital Stat Rep 60:1–95PubMed

11.

Levinson AH, Perez-Stable EJ, Espinoza P, Flores ET, Byers TE (2004) Latinos report less use of pharmaceutical aids when trying to quit smoking. Am J Prev Med 26:105–111PubMedCrossRef

12.

Cokkinides VE, Halpern MT, Barbeau EM, Ward E, Thun MJ (2008) Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey. Am J Prev Med 34:404–412PubMedCrossRef

13.

Lopez-Quintero C, Crum RM, Neumark YD (2006) Racial/ethnic disparities in report of physician-provided smoking cessation advice: analysis of the 2000 National Health Interview Survey. Am J Public Health 96:2235–2239PubMedCrossRef

14.

Sonnenfeld N, Schappert SM, Lin SX (2009) Racial and ethnic differences in delivery of tobacco-cessation services. Am J Prev Med 36:21–28PubMedCrossRef

15.

Houston TK, Scarinci IC, Person SD, Greene PG (2005) Patient smoking cessation advice by health care providers: the role of ethnicity, socioeconomic status, and health. Am J Public Health 95:1056–1061PubMedCrossRef

16.

Zinser MC, Pampel FC, Flores E (2011) Distinct beliefs, attitudes, and experiences of Latino smokers: relevance for cessation interventions. Am J Health Promot 25:eS1–eS15PubMedCrossRef

17.

Brandon TH, Collins BN, Juliano LM, Lazev AB (2000) Preventing relapse among former smokers: a comparison of minimal interventions through telephone and mail. J Consult Clin Psychol 68:103–113PubMedCrossRef

18.

Brandon TH, Meade CD, Herzog TA, Chirikos TN, Webb MS, Cantor AB (2004) Efficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: dismantling the effects of amount of content versus contact. J Consult Clin Psychol 72:797–808PubMedCrossRef

19.

Quinn GP, Hauser K, Bell-Ellison BA, Rodriguez NY, Frias JL (2006) Promoting pre-conceptional use of folic acid to Hispanic women: a social marketing approach. Matern Child Health J 10:403–412PubMedCrossRef

20.

Simmons VN, Quinn G, Litvin EB, Rojas A, Jimenez J, Castro E, Meade CD, Brandon TH (2011) Transcreation of validated smoking relapse-prevention booklets for use with Hispanic populations. J Health Care Poor Underserved 22:886–893PubMedCrossRef

21.

Ellis P, Robinson P, Ciliska D, Armour T, Brouwers M, O’Brien MA, Sussman J, Raina P (2005) A systematic review of studies evaluating diffusion and dissemination of selected cancer control interventions. Health Psychol 24:488–500PubMedCrossRef

22.

Leech N, Onwuegbuzie A (2008) Qualitative data analysis: a compendium of techniques and a framework for selection for school psychology research and beyond. School Psychol Quart 23:587–604CrossRef

23.

Kraemer HC (2003) "Rules" of evidence in assessing the efficacy and effectiveness of treatments. Dev Neuropsychol 24:705–718PubMed

24.

Litvin EB, Rojas A, Brandon TH, Quinn G, Vadaparampil S, Gwede C, Jimenez J, Castro E, Diaz Z, Simmons VN (2011) Cultural acceptabilility of a smoking relapse prevention intervention for pregnant women in Puerto Rico: providers’ feedback. Hisp Health Care Int 9:117–126CrossRef

25.

Lopez EN, Simmons VN, Quinn GP, Meade CD, Chirikos TN, Brandon TH (2008) Clinical trials and tribulations: lessons learned from recruiting pregnant ex-smokers for relapse prevention. Nicotine Tob Res 10:87–96PubMedCrossRef

Title: Distribution of Smoking Relapse Prevention Materials in the Hispanic Community: Lessons Learned
Authors: Anamaría Bejarano
Erika B. Litvin
Gwendolyn P. Quinn
Thomas H. Brandon
Vani Nath Simmons
Publication date: 01-03-2013
Publisher: Springer-Verlag
Published in: Journal of Cancer Education / Issue 1/2013
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI: https://doi.org/10.1007/s13187-012-0422-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2013

Testing Messages to Encourage Discussion of Clinical Trials Among Cancer Survivors and Their Physicians: Examining Monitoring Style and Message Detail

Smartphone Apps as a Source of Cancer Information: Changing Trends in Health Information-Seeking Behavior

Improving Sun-Safe Knowledge, Attitude and Behaviour in Parents of Primary School Children: a Pilot Study

Survivorship Clinic Group Educational Sessions: Adoption, Acceptance, and Attendance

Skin Cancer Education among Massage Therapists: A Survey at the 2010 Meeting of the American Massage Therapy Association

Reproductive Health in the Adolescent and Young Adult Cancer Patient: an Innovative Training Program for Oncology Nurses

Keynote webinar | Spotlight on antibody–drug conjugates in cancer